Ex-Pharma CEO Asks Justices To Review $1M In Tax Penalties
A former pharmaceutical CEO asked the U.S. Supreme Court to review a Third Circuit decision upholding $1 million in Internal Revenue Service penalties against him for failing to report a Swiss...To view the full article, register now.
Already a subscriber? Click here to view full article